Best Practices for Lean Six Sigma in Clinical Development and R&D
Wednesday, April 17, 2013 | ARCHIVE NOW AVAILABLE
Lean and Six Sigma are complementary strategies which offer significant benefits when implemented individually, however when applied together in a cohesive, integrated approach, their synergies yield further improvements in throughput, reproducibility and quality. Over time, Lean Six Sigma will become a seamless and critical operational strategy that will enable lasting change and significant improvements in efficiency and productivity.
The speaker will examine the move in the pharma/biotech industry to the adoption and implementation of Lean Six Sigma. Key areas of discussion include:
Lean Six Sigma methodology applied to clinical research
- Why is Lean Six Sigma important in clinical research?
- What strategies can be used to improve clinical research processes?
- How can Lean Six Sigma tools be used to help make clinical research more efficient & cost effective?
In addition, participants will gain an understanding of:
- Using Six Sigma to tackle imperfections and variations in drug discovery & development
- How industries can eliminate waste and minimize variation in process streams, thereby improving the quality, reliability and reproducibility of outcomes
Case studies will be cited and a live Q&A with the audience will follow the main presentation.
Hub Unit Manager,
Regional Clinical Operations Office,
Rodrigo Crispim has worked in his current position as Hub Unit Manager in Sao Paulo, Brazil since January 2011. As of January 2013 he is also responsible for managing the portfolio of Lean Sigma projects from Global Development Operations.
Mr. Crispim has eight years experience in clinical research at Bristol-Myers Squibb, including working as protocol manager at BMS headquarters in the United States in 2010 and managing the site monitoring team in Sao Paulo, Brazil for three years. Before that, he was a clinical site monitor participating in studies in cardiovascular, immunology, metabolic, neuroscience and oncology.
In 2009 Mr. Crispim was trained in Lean Six Sigma and obtained his certification in 2011 after leading process improvement events in Latin America for Study Start-up and other clinical trial processes.